The Synergistic Effects of the Combination of Ciprofloxacin and Temozolomide on Human Glioblastoma A-172 Cell Line

Journal Title: Middle East Journal of Cancer - Year 2017, Vol 8, Issue 1

Abstract

Background: Combination therapy has generated remarkable motivation in the clinical setting since it boosts the therapeutic potential of anticancer drugs. Glioblastoma multiforme (GBM) is the most common and aggressive malignant brain tumor which affects patients in all ages, and being principally resistant to treatment. Methods: In this study, temozolomide as a standard chemotherapeutic drug for Human GBM, was combined with ciprofloxacin to know whether ciprofloxacin can potentiate the cytotoxic effects of temozolomide. Glioblastoma A-172 cell line was exposed to ciprofloxacin and temozolomide either alone or in combination for 24, 48 and 72 h. Cytotoxicity was measured by MTT assay. Results: Ciprofloxacin and temozolomide induced tumor cell death in a dose-dependent manner with an IC50 value of 259.3 μM for ciprofloxacin and 62.5 μM for temozolomide in 72 h. These values shifted to 22.8 μM for ciprofloxacin and 8.6 μM for temozolomide in the presence of IC50 of the other drug. The combination-index (CI) values were found less than 1. Conclusion: These results indicate synergism across a broad range of concentrations of ciprofloxacin and temozolomide in glioblastoma tumor cell line and that CPF increased the anti-tumor cytotoxic effect of TMZ in glioblastoma A-172 cell line.

Authors and Affiliations

Ashkan Zandi, Taraneh Moini Zanjani, Seyed Ali Ziai, Yalda Khazaei Poul, Mostafa Haji Molla Hoseini

Keywords

Related Articles

Interplay between CKS2, N-cadherin, and PD-ECGF in Non-Schistosomal and Schistosomal-Associated Bladder Cancer: A Prospective Comparative Study in the Egyptian Population

Background: The current study investigated the possible role of the cell cycle regulator, cyclin-dependent kinases regulatory subunit-2; the angiogenic factor, plateletderived endothelial cell growth factor; and the cell...

Psychological Distress in Cancer Patients

Background: The psychological distress is a kind of mental stress that people experience due to various causes. This study was performed aimed to investigate the psychological distress in cancer patients. Methods: This...

Evaluation of Promoter Hypermethylation of Tumor-Suppressor Genes p14 and p16 in Iranian Endometrial Carcinoma Patients

Background: Endometrial cancer is a common gynecological malignancy with good prognosis in the early stages of the disease. The CpG island in the promoter region of tumor-suppressor genes are frequently methylated in var...

Clinical Significance of BRAF and ZEB2 Expressions in Healthy Adjacent Tissue of Bladder Cancer

Background: Numerous molecular changes are involved in the development and progression of bladder cancer. Regular follow-up of patients is crucial due to the high recurrence rate of bladder cancer. The aim of this study...

The Age-standardized Incidence Rate of Ovarian Cancer in Iranian Women: A Systematic Review and Meta-analysis

Background: Cancer is the leading cause of morbidity and mortality worldwide. Among gynecological cancers, ovarian cancer is the first cause of cancer-related deaths. However, only a few studies have evaluated the age-st...

Download PDF file
  • EP ID EP298042
  • DOI -
  • Views 113
  • Downloads 0

How To Cite

Ashkan Zandi, Taraneh Moini Zanjani, Seyed Ali Ziai, Yalda Khazaei Poul, Mostafa Haji Molla Hoseini (2017). The Synergistic Effects of the Combination of Ciprofloxacin and Temozolomide on Human Glioblastoma A-172 Cell Line. Middle East Journal of Cancer, 8(1), 31-38. https://europub.co.uk/articles/-A-298042